Results 211 to 220 of about 610,991 (261)

Corrigendum to 'Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis' [The American Journal of Cardiology 205 (2023) 20-27]. [PDF]

Am J Cardiol
Churchill R, Sykora D, Castrichini M, Arment C, Myasoedova E, Elwazir M, Bois J, Young K, Rosenbaum A.   +8 more
europepmc   +1 more source

Single‐Cell Reveal GALNT7‐Dependent Ferroptosis Suppression as a Mechanism of Immunotherapy Resistance in Non‐Small Cell Lung Cancer

Advanced Science, EarlyView.
Integrated clinical and mechanistic analyses identify GALNT7 as a ferroptosis‐suppressive regulator associated with immunotherapy resistance in non‐small cell lung cancer. GALNT7 depletion promotes lipid peroxidation, mitochondrial dysfunction, and ferroptosis, enhances CD8+ T‐cell activation and IFN‐γ production, and sensitizes tumors to PD‐1 blockade,
Jiadi Gan, Qian Zheng, Deng Liu, Ruichao Nie, Menglin Yao, Xiaolong Tang, Renjie Xu, Jinghong Xian, Wenjun Meng, Wenxin Luo, Dan Liu, Guiyi Ji   +11 more
wiley   +1 more source

Adalimumab-Associated Sensory Neuropathy in a Young Patient With Spondyloarthritis: A Complication of Anti-tumor Necrosis Factor Therapy. [PDF]

Cureus
Konnepati S, Ingle V, Pawar A, Khan F, Sharma A.   +4 more
europepmc   +1 more source

Prebiotic Diet Enhances Suppression of Tumor Necrosis Factor-Alpha Production in Response to Lipopolysaccharide after Exhaustive Exercise.

Neuroimmunomodulation
Yano H, Fujii R, Tahara R, Watanabe C, Hamada H, Kono T, Aoki T, Kremenik MJ, Oyanagi E.   +8 more
europepmc   +1 more source

Risk of disseminated tuberculosis and other infections after neonatal Bacillus Calmette-Guérin vaccination in infants with <i>in-utero</i> exposure to tumor necrosis factor-α inhibitors. [PDF]

Front Med (Lausanne)
Al Emadi S, Alebbi S, Hadwan N, Alsaed O, Cackamvalli PM, Abunahia N, Satti E.   +6 more
europepmc   +1 more source

High Soluble Tumor Necrosis Factor Receptor 2 in Serum Is Associated With Inferior Overall Survival Across Major Lymphoma Subtypes. [PDF]

Am J Hematol
Khurana A, Hayashi H, Thach B, Yang ZZ, Negaard BJ, Cerhan JR, Novak AJ, Link BK, Habermann TM, Feldman AL, Parikh SA, Slager SL, Ansell SM, Maurer MJ, Faustman DL.   +14 more
europepmc   +1 more source

Influence of <i>Fusobacterium nucleatum</i> on Tumor Necrosis Factor Alpha Therapy in Ulcerative Colitis. [PDF]

Mediators Inflamm
Şenyüz B, Ünal NG, Yakut BD, Uzel A, Gündüz C, Süslüer SY.   +5 more
europepmc   +1 more source

Correction to "Newly Synthesized Indolylacetic Derivatives Reduce Tumor Necrosis Factor-Mediated Neuroinflammation and Prolong Survival in Amyotrophic Lateral Sclerosis Mice". [PDF]

ACS Pharmacol Transl Sci
Corvino A, Caliendo G, Fiorino F, Frecentese F, Valsecchi V, Lombardi G, Anzilotti S, Andreozzi G, Scognamiglio A, Sparaco R, Perissutti E, Severino B, Gargiulo M, Santagada V, Pignataro G.   +14 more
europepmc   +1 more source

Increased Tumor Necrosis Factor Superfamily Members in Neuroinflammatory Schizophrenia and Bipolar Disorder Midbrains. [PDF]

Biol Psychiatry Glob Open Sci
Mendez-Victoriano G, Zhu Y, Neuhaus L, Shaik S, Middleton F, Kondo Y, Fayyazuddin A, Hoeppner D, Puvogel S, Alsema A, Kracht L, Matsumoto M, Eggen BJL, Walker AK, Webster MJ, Sommer IEC, Weickert CS.   +16 more
europepmc   +1 more source